IndiaOne Finance - Company Dashboard

Governance Classic Home

Gennex Laboratories LtdPharmaceuticalsINE509C01026Standalone₹10.27-0.16 (-1.53%)Jun-26

Valuation

Market Cap₹249.51 Cr

TTM PE15.56x

Forward PE16.39x

PEG0.49

Book Value₹7.68

P/B1.34x

TTM EPS₹0.66

Fwd EPS₹0.63

TTM Revenue₹128.90 Cr

TTM PAT₹15.93 Cr

TTM EBITDA₹13.42 Cr

TTM EBIT₹12.41 Cr

Last Qtr PAT₹3.96 Cr

Last Qtr EBITDA₹2.96 Cr

Last Qtr EBIT₹2.72 Cr

Profitability

ROE8.53%

ROCE10.00%

TTM NPM12.36%

TTM EBITDA %10.41%

Curr OPM11.40%

Last OPM8.15%

Curr NPM—

Last NPM—

Curr EPS₹0.16

Last EPS₹0.13

Balance sheet

Equity₹22.74 Cr

Reserve₹163.94 Cr

Total Debt₹10.22 Cr

D/E0.05x

Interest %12.88%

Curr Interest₹0.51 Cr

Price / range

Close₹10.27

vs 52W High-40.46%

vs 52W Low+45.67%

MA50—

MA200—

Returns

1D-1.53%

1W-6.97%

1M-14.42%

3M-3.48%

6M+8.22%

1Y-20.57%

2Y-63.15%

3Y+31.67%

5Y+41.66%

Diwali-30.47%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	34.68+35.3%	36.71	28.18	29.33	25.64	119.86
Other Income	2	1.30	2.54	2.04	2.26	8.14
Total Income	36.68+31.5%	38.01	30.71	31.37	27.90	128
Interest	0.51	0.63	0.69	0.56	0.59	2.47
Expenditure	-32.47-41.2%	-34.81	-25.46	-26.14	-23	-109.76
PBDT	0	0	0	0	0	0
EBITDA	2.96-13.7%	2.88	3.62	3.96	3.43	13.54
Depreciation	-0.24	-0.35	-0.21	-0.21	-0.20	-0.97
EBIT	2.72-15.8%	2.53	3.41	3.75	3.23	12.57
PBT	4.21-13.2%	3.20	4.95	5.23	4.85	18.24
Tax	-0.25	-0.21	-0.50	-0.70	-0.70	-2.11
Equity	0	0	0	0	0	0
OPM	12.13	8.72	17.57	17.84	18.92	14.00
Net Profit	3.96-4.6%	2.99	4.45	4.53	4.15	16.13
NPM	11.40	8.15	15.80	15.46	16.19	13.00
EPS	0.16	0.13	0.18	0.19	0	0.67

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	119.86+26.7%	94.58+41.6%	66.80+2.6%	65.10+6.4%	61.21+2.6%	59.65
Other Income	8.14	9.22	4.30	3.40	1.38	0.52
Total Income	128+23.3%	103.80+46.0%	71.10+3.8%	68.50+9.4%	62.60+4.0%	60.17
Expenditure	-109.76-26.5%	-86.74-53.9%	-56.35+9.8%	-62.49-8.7%	-57.50-5.0%	-54.74
Interest	-2.47	-1.58	-1.16	-1.23	-0.88	-0.74
PBDT	0	0	0	0	0	0
EBITDA	13.54+32.9%	10.19-18.0%	12.42+171.2%	4.58-14.9%	5.38-17.6%	6.53
Depreciation	-0.97	-0.77	-0.81	-0.74	-0.79	-0.88
EBIT	12.57+33.4%	9.42-18.9%	11.61+202.3%	3.84-16.3%	4.59-18.8%	5.65
PBT	18.24+6.9%	17.06+15.6%	14.76+145.6%	6.01+18.1%	5.09+0.6%	5.06
Tax	-2.11	-3.02	-2.96	-1.45	-1.17	-1.02
Equity	0	22.74	0	0	0	0
OPM (%)	14.00	16.44	21.00	9.00	8.00	8.00
Net Profit	16.13+14.9%	14.04+19.0%	11.80+158.8%	4.56+16.3%	3.92-3.0%	4.04
NPM (%)	13.00	13.52	17.00	7.00	6.00	7.00
EPS (Rs)	0.67+8.1%	0.62-11.4%	0.70+169.2%	0.26-21.2%	0.33+3.1%	0.32
CEPS	0.67	0.61	0.64	0.26	0.33	0.32

Metric	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	FY24-25
Revenue	40.37+7.1%	37.24	34.18	40.33	37.71	137.90
Other Income	2.59	2.06	2.28	3.83	2.30	10.43
Total Income	42.96+7.4%	39.30	36.46	44.16	40.01	148.33
Interest	1.11	1.03	0.98	1.20	0.84	3.61
Expenditure	-36.01-5.3%	-33.24	-30.50	-40.20	-34.19	-126.93
PBDT	0	0	0	0	0	0
EBITDA	5.99+23.3%	5.50	5.16	1.87	4.86	16.57
Depreciation	-0.52	-0.47	-0.50	-0.54	-0.50	-1.99
EBIT	5.47+25.5%	5.03	4.66	1.33	4.36	14.58
PBT	6.64+14.1%	6.06	5.87	3.96	5.82	21.40
Tax	-0.65	-0.55	-0.80	-0.80	-0.75	-3.27
Equity	0	0	0	0	0	22.74
OPM	15.46	15.42	16.09	8.96	14.54	14.43
Net Profit	5.99+18.1%	5.51	5.02	3.07	5.07	18.12
NPM	13.95	14.02	13.76	6.95	12.66	12.22
EPS	0.22+0.0%	0.21	0.22	0.13	0.22	0.79

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 24-25	FY 23-24	FY 22-23
Revenue	137.90+59.0%	86.71+32.2%	65.60
Other Income	10.43	4.91	3.95
Total Income	148.33+61.9%	91.62+31.7%	69.56
Expenditure	-126.93-68.9%	-75.13-18.9%	-63.18
Interest	-3.61	-3.08	-1.35
PBDT	0	0	0
EBITDA	16.57-2.7%	17.03+263.1%	4.69
Depreciation	-1.99	-2.37	-0.92
EBIT	14.58-0.5%	14.66+288.9%	3.77
PBT	21.40+29.8%	16.49+158.9%	6.37
Tax	-3.27	-3.32	-1.45
Equity	22.74	0	0
OPM (%)	14.43	18.00	9.16
Net Profit	18.12+37.5%	13.18+167.9%	4.92
NPM (%)	12.22	14.38	7.07
EPS (Rs)	0.79+17.9%	0.67+91.4%	0.35
CEPS	0.78	0.61	0.35

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

Year	Ratio	Ex-Date
2009	Rs.10/- to Rs.1/-	14 Dec 2009

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split